Brainstorm Cell Therapeutics Inc. (BCLI) fell -5.22% or -0.17 to $3.09. It is near 35587 shares traded, which is 79.2% compare to the average total volume 44934. The market cap of BCLI is $58.93 million. The year to date change is -10.68%. The 52 week price range is from $2.88 to $5.18. Price of BCLI have changed 0.31% during last week. It have changed 8.31% over last month, 8.31% over last 3 months, -19.31% over last 6 months and -18.70% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for BCLI is 3.34. It is 8.09% above current price. The 200-day Moving Averages for BCLI is 3.93. It is 27.18% above current price. The 52-week High is 5.18. It is 67.64% from the current price. The 52-week Low is 2.88. It is -6.80% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of BCLI is 24.33 on 2018-02-28. Short % to float is 8.37%. There are some statistics of BCLI. It is has market cap $58.93 million. The share outstanding is 19.07 million. The average volume is 44934. The percent of top 15 Institution holding is 8.30%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of BCLI is -57.66%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of BCLI is -41.78%.